A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients.

@article{Qiao2014ATF,
  title={A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients.},
  author={Li-yan Qiao and Fang-jie Huang and Mangsuo Zhao and Jing-Hui Xie and Jie Shi and Jing Wang and Xian-zhong Lin and Huancong Zuo and Yun-liang Wang and Tong-chao Geng},
  journal={Cell transplantation},
  year={2014},
  volume={23 Suppl 1},
  pages={S65-72}
}
Stem cell therapy is an emerging therapeutic modality in the treatment of stroke. We assessed the safety and feasibility of the cotransplantation of neural stem/progenitor cells (NSPCs) and mesenchymal stromal cells (MSCs) in patients with ischemic stroke. Eight patients were enrolled in this study. All patients had a hemisphere with infarct lesions located on one side of the territories of the cerebral middle or anterior arteries as revealed with cranial magnetic resonance imaging (MRI). The… CONTINUE READING
16 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…